Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis

Critical Care

Volumn 15, Issue 2, 2011, Pages

  Heininger, Alexandra ^a   Haeberle, Helene ^a   Fischer, Imma ^b,c   Beck, Robert ^a   Riessen, Reimer ^a   Rohde, Frank ^b   Meisner, Christoph ^c   Jahn, Gerhard ^a   Koenigsrainer, Alfred ^a   Unertl, Klaus ^a   Hamprecht, Klaus ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b Biostatistik Tübingen ^*  (Germany)

^c Institut fur Medizinische Biometrie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CRITICALLY ILL PATIENT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA CONTENT; DNA DETERMINATION; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LEUKOCYTE; LONGITUDINAL STUDY; LUNG GAS EXCHANGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PLASMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEPSIS; SEROLOGY; VIRUS REACTIVATION; CRITICAL ILLNESS; DOUBLE BLIND PROCEDURE; MIDDLE AGED; PHYSIOLOGY; STATISTICS; TREATMENT OUTCOME; VIROLOGY; VIRUS ACTIVATION;

AGED; CRITICAL ILLNESS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DOUBLE-BLIND METHOD; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; SEPSIS; TREATMENT OUTCOME; VIRUS ACTIVATION;

EID: 79952084722     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10069     Document Type: Article

References (33)

1. Munoz-Price LS, Slifkin M, Ruthazer R, Poutsiaka DD, Hadley S, Freeman R, Rohrer R, Angelis M, Cooper J, Fairchild R, Barefoot L, Bloom J, Fitzmaurice S, Snydman DR. The clinical impact of ganciclovir prophylaxis on the occurrence of bacteremia in orthotopic liver transplant recipients. Clin Infect Dis 2004, 39:1293-1299. 10.1086/425002, 15494905.
2. Kalil AC, Levitsky J, Lyden E, Stoner J, Freifeld AG. Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients. Ann Intern Med 2005, 143:870-880.
3. deJong MD, Galasso GJ, Gazzard B, Griffiths PD, Jabs DA, Kern ER, Spector SA. Summary of the II International Symposium on Cytomegalovirus. Antiviral Res 1998, 39:141-162. 10.1016/S0166-3542(98)00044-8, 9833956.
4. Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002, 34:1094-1097. 10.1086/339329, 11914998.
5. Sinclair J, Sissons P. Latency and reactivation of human cytomegalovirus. J Gen Virol 2006, 87:1763-1779. 10.1099/vir.0.81891-0, 16760381.
6. Boeckh M, Ljungman P. How we treat cytomegalovirus in hematopoietic cell transplant recipients. Blood 2009, 113:5711-5719. 10.1182/blood-2008-10-143560, 2700312, 19299333.
7. Gandhi MK, Khanna R. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis 2004, 4:725-738. 10.1016/S1473-3099(04)01202-2, 15567122.
8. Heininger A, Jahn G, Engel C, Notheisen T, Unertl K, Hamprecht K. Human cytomegalovirus infections in nonimmunosuppressed critically ill patients. Crit Care Med 2001, 29:541-547. 10.1097/00003246-200103000-00012, 11373417.
9. Chiche L, Forel JM, Roch A, Guervilly C, Pauly V, lardet-Servent J, Gainnier M, Zandotti C, Papazian L. Active cytomegalovirus infection is common in mechanically ventilated medical intensive care unit patients. Crit Care Med 2009, 37:1850-1857. 10.1097/CCM.0b013e31819ffea6, 19384219.
10. Jaber S, Chanques G, Borry J, Souche B, Verdier R, Perrigault PF, Eledjam JJ. Cytomegalovirus infection in critically ill patients: associated factors and consequences. Chest 2005, 127:233-241. 10.1378/chest.127.1.233, 15653989.
11. Cook CH, Martin LC, Yenchar JK, Lahm MC, McGuinness B, Davies EA, Ferguson RM. Occult herpes family viral infections are endemic in critically ill surgical patients. Crit Care Med 2003, 31:1923-1929. 10.1097/01.CCM.0000070222.11325.C4, 12847384.
12. Kutza AS, Muhl E, Hackstein H, Kirchner H, Bein G. High incidence of active cytomegalovirus infection among septic patients. Clin Infect Dis 1998, 26:1076-1082. 10.1086/520307, 9597229.
13. Limaye AP, Kirby KA, Rubenfeld GD, Leisenring WM, Bulger EM, Neff MJ, Gibran NS, Huang ML, Santo Hayes TK, Corey L, Boeckh M. Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA 2008, 300:413-422. 10.1001/jama.300.4.413, 2774501, 18647984.
14. Rafailidis PI, Mourtzoukou EG, Varbobitis IC, Falagas ME. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J 2008, 5:47. 10.1186/1743-422X-5-47, 2289809, 18371229.
15. Luyt CE, Combes A, Deback C, Aubriot-Lorton MH, Nieszkowska A, Trouillet JL, Capron F, Agut H, Gibert C, Chastre J. Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation. Am J Respir Crit Care Med 2007, 175:935-942. 10.1164/rccm.200609-1322OC, 17234903.
16. von Muller L, Klemm A, Weiss M, Schneider M, Suger-Wiedeck H, Durmus N, Hampl W, Mertens T. Active cytomegalovirus infection in patients with septic shock. Emerg Infect Dis 2006, 12:1517-1522.
17. Cook CH, Yenchar JK, Kraner TO, Davies EA, Ferguson RM. Occult herpes family viruses may increase mortality in critically ill surgical patients. Am J Surg 1998, 176:357-360. 10.1016/S0002-9610(98)00205-0, 9817255.
18. Kalil AC, Florescu DF. Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit. Crit Care Med 2009, 37:2350-2358. 10.1097/CCM.0b013e3181a3aa43, 19531944.
19. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655. 10.1378/chest.101.6.1644, 1303622.
20. Le Gall, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270:2957-2963. 10.1001/jama.270.24.2957, 8254858.
21. Hamprecht K, Mikeler E, Jahn G. Semi-quantitative detection of cytomegalovirus DNA from native serum and plasma by nested PCR: influence of DNA extraction procedures. J Virol Methods 1997, 69:125-135. 10.1016/S0166-0934(97)00148-1, 9504758.
22. Hamprecht K, Pfau M, Schaller HE, Jahn G, Middeldorp JM, Rennekampff HO. Human cytomegalovirus infection of a severe-burn patient: evidence for productive self-limited viral replication in blood and lung. J Clin Microbiol 2005, 43:2534-2536. 10.1128/JCM.43.5.2534-2536.2005, 1153747, 15872305.
23. Jacobi C, Riessen R, Schumacher U, Autenrieth IB, Jahn G, Gregor M, Raible A, Hamprecht K. Life-threatening pneumonia caused by human cytomegalovirus and Mycloplasma pneumoniae coinfection in a young, immunocompetent patient. J Med Microbiol 2010, 59:980-983. 10.1099/jmm.0.017988-0, 20466842.
24. Burrows J, Nitsche A, Bayly B, Walker E, Higgins G, Kok T. Detection and subtyping of Herpes simplex virus in clinical samples by LightCycler PCR, enzyme immunoassay and cell culture. BMC Microbiol 2002, 2:12. 10.1186/1471-2180-2-12, 116582, 12069697.
25. Hamprecht K, Steinmassl M, Einsele H, Jahn G. Discordant detection of human cytomegalovirus DNA from peripheral blood mononuclear cells, granulocytes and plasma: correlation to viremia and HCMV infection. J Clin Virol 1998, 11:125-136. 10.1016/S1386-6532(98)00046-4, 9785214.
26. Ziemann M, Sedemund-Adib B, Reiland P, Schmucker P, Hennig H. Increased mortality in long-term intensive care patients with active cytomegalovirus infection. Crit Care Med 2008, 36:3145-3150. 10.1097/CCM.0b013e31818f3fc4, 18936696.
27. Osawa R, Singh N. Cytomegalovirus infection in critically ill patients: a systematic review. Crit Care 2009, 13:R68. 10.1186/cc7875, 2717427, 19442306.
28. Linssen CF, Jacobs JA, Stelma FF, van Mook WN, Teporten P, Vink C, Drent M, Bruggeman CA, Smismans A. Herpes simplex virus load in bronchoalveolar lavage fluid is related to poor outcome in critically ill patients. Intensive Care Med 2008, 34:2202-2209. 10.1007/s00134-008-1231-4, 18679655.
29. Prosch S, Wendt CE, Reinke P, Priemer C, Oppert M, Kruger DH, Volk HD, Docke WD. A novel link between stress and human cytomegalovirus (HCMV) infection: sympathetic hyperactivity stimulates HCMV activation. Virology 2000, 272:357-365. 10.1006/viro.2000.0367, 10873779.
30. Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol 2007, 165:710-718. 10.1093/aje/kwk052, 17182981.
31. Tuxen DV, Wilson JW, Cade JF. Prevention of lower respiratory Herpes simplex virus infection with acyclovir in patients with the adult respiratory distress sndrome. Am Rev Respir Dis 1987, 136:402-405.
32. Heininger A, Vogel U, Aepinus C, Hamprecht K. Disseminated fatal human cytomegalovirus disease after severe trauma. Crit Care Med 2000, 28:563-566. 10.1097/00003246-200002000-00046, 10708201.
33. Cook C, Zhang Y, Sedmak DD, Martin LC, Jewell S, Ferguson RM. Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice. Crit Care Med 2006, 34:842-849. 10.1097/01.CCM.0000191711.89494.2D, 1894751, 16521279.